| Specialty Retail Industry | Consumer Discretionary Sector | Ziv Turner CEO | OTCQB Exchange | 67109N108 CUSIP |
| IL Country | 9 Employees | - Last Dividend | 26 Oct 2012 Last Split | - IPO Date |
OWC Pharmaceutical Research Corp., operating through its subsidiary One World Cannabis Ltd., is a pioneering force in the field of cannabis-based medical research and development. Established in 2008 and headquartered in Ramat Gan, Israel, the company has dedicated itself to the creation of cannabis-derived medical solutions aimed at addressing a wide array of conditions. Originally known as Dynamic Applications Corp., the organization underwent a rebranding to OWC Pharmaceutical Research Corp. in December 2014, marking a significant pivot towards a focus on medical cannabis research. With a broad spectrum of studies aimed at harnessing the therapeutic potentials of cannabis, OWC Pharmaceutical Research Corp. represents a firm commitment to advancing medical science for better patient outcomes worldwide.
The offerings of OWC Pharmaceutical Research Corp. encompass a diverse range of products and research initiatives designed to meet the needs of patients suffering from various conditions. Each product and service is a testament to the company’s innovation and dedication to medical cannabis research.
OWC Pharmaceutical Research Corp. is actively engaged in the development of treatments that leverage the healing properties of cannabis. These products target ailments such as multiple myeloma, psoriasis, post-traumatic stress disorder (PTSD), chronic pain, and fibromyalgia. Through rigorous research and clinical trials, the company endeavors to create effective cannabis-based therapies that offer relief and improve the quality of life for patients affected by these conditions.
The company is at the forefront of pharmaceutical innovation with its cannabis soluble tablet delivery system. This novel approach aims at offering a more efficient and patient-friendly method of administering cannabis-based medications, enhancing the efficiency and consistency of dosing for therapeutic purposes.
In addition to product development, OWC Pharmaceutical Research Corp. extends its expertise to offer consulting services. These services cater to companies and governmental agencies looking for guidance on international medical cannabis protocols and regulations. By providing insight into the complex landscape of medical cannabis policy and application, OWC Pharmaceutical Research helps entities navigate the burgeoning medical cannabis sector with informed confidence.